Tata Institute doctors claim new drug can stop cancer resurgence. It costs Rs 100

Doctors and researchers at Tata Institute in Mumbai have developed a tablet, claiming that it can prevent cancer from occurring again.

This innovative tablet, which results from extensive research and testing over a decade, is believed to not only prevent cancer recurrence in patients but also reduce side effects associated with treatments like radiation and chemotherapy by 50%.

Dr Rajendra Badve, a senior cancer surgeon at Tata Memorial Hospital and part of the research group, explained the process behind the discovery.

“Human cancer cells were inserted in rats for the research, which formed a tumour in them. The rats were then treated with radiation therapy, chemotherapy and surgery. It was found that when these cancer cells die, they break into tiny pieces called chromatin particles. These particles can travel to other parts of the body through the bloodstream and when they enter healthy cells, they can turn them cancerous,” Dr Badve told NDTV.

In response to this problem, the researchers administered pro-oxidant tablets containing resveratrol and copper (R+Cu) to the rats. The R+Cu tablets generate oxygen radicals, effectively destroying chromatin particles.